Kase, Yoshitaka
Morikawa, Satoru
Okano, Yuji
Hosoi, Tatsuya
Yasui, Takazumi
Taki-Miyashita, Yoko
Yakabe, Mitsutaka
Goto, Maraku
Ishihara, Kazuyuki
Ogawa, Sumito
Nakagawa, Taneaki
Okano, Hideyuki https://orcid.org/0000-0001-7482-5935
Funding for this research was provided by:
KAKEN (22K09930)
ONUKI-KIKIN
Article History
Received: 22 November 2024
Accepted: 16 January 2025
First Online: 3 February 2025
Declarations
:
: All animal experiments were conducted in accordance with the Institutional Guidelines on Animal Experimentation at Keio University (Tokyo, Japan) and approved by the Keio University Institutional Animal Care and Use Committee (A2023-003) and the Animal Care Committee of the Tokyo Dental College (220,601, 230,602, and 240,602). All methods were performed in compliance with the ARRIVE guidelines.
: Not applicable.
: HO is a compensated scientific consultant for San Bio Co., Ltd., Kringle Pharma, Inc., and a Director and Chief Science Officer of K Pharma, Inc. HO is an Editor-in-Chief of Inflammation and Regeneration. YK is an Editorial Board Member of Inflammation and Regeneration.